MIG Capital Overview

MIG Capital AG is a leading German venture capital firm headquartered in Munich, specializing in investments in deep tech and life sciences companies across Europe. Since its inception in 2004, MIG Capital has supported founders in developing innovative solutions and transforming visions into successful businesses. The firm manages 18 funds with approximately €1.3 billion in committed capital, investing in sectors such as biopharmaceuticals, energy and environmental technologies, advanced computing, digitalization/IoT, medical technology, and digital health. MIG Capital's investment team comprises engineers, scientists, physicians, and entrepreneurs who leverage their expertise to assess business models and technologies, providing portfolio companies with access to a vast network of institutions and decision-makers. The firm's portfolio includes 33 active companies, with notable exits like Siltectra (acquired by Infineon) and Hemovent (acquired by MicroPort), as well as IPOs of companies such as BRAIN, NFON, BioNTech, and Immatics.

Is MIG Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with MIG Capital, along with a list of other relevant VCs, is available on Hopohopo.io.